The findings suggest that methylphenidate and psychosocial treatments, whether used individually or in combination, are effective for managing ADHD symptoms.

Stimulant medications, such as methylphenidate, exhibit a strong effect size for ADHD treatment, aligning with the observed outcomes.

For younger children with moderate-to-severe ADHD, methylphenidate is recommended when behavioral interventions are insufficient.

Combining behavioral therapy with stimulant medication shows positive results, particularly in pre-adolescent children.

The MTA study highlighted the additional benefits of combining these treatments based on parent and teacher ratings.

Behavioral therapy, which involves modifying the child's environment, enhances overall ADHD management, especially when coordinated between home and school.

Building upon the paper's finding that methylphenidate improves social behaviors, it's noteworthy that children with ADHD often struggle with social cues and relationships.

Medication alone helps these children better understand nonverbal cues.

However, adding social skills training to medication offers limited additional benefits for improving social skills.

Building upon the findings that both methylphenidate and combined treatments reduce ADHD symptoms,

this slide explores how ADHD impacts organizational skills in children and adults.

While medications like Ritalin can be effective, therapy and targeted interventions are also beneficial.

These approaches are especially promising for improving skills among college students.

Building upon the discussion of treatment efficacy from the paper above, ADHD medications such as Vyvanse, Adderall, and Dexamphetamine show significant benefits.

These drugs enhance focus, maintain on-task behavior, and improve task completion.

The result is better academic performance and overall classroom success.